Biology Lab, Adelphi University Garden City, NY Sep 2013 to Jun 2014 Graduate Research AssistantEstee Lauder Research, Department of Skin Physiology and Pharmacology Melville, NY Feb 2014 to May 2014 Internship Research AssistantFeinstein Institute for Medical Research Manhasset, NY Nov 2013 to Mar 2014 Clinical Research VolunteerBeijing Normal University
Sep 2011 to Nov 2011 Undergraduate Research AssistantChinese Academy of Agriculture Science
Jun 2008 to Aug 2008 Summer Research Assistant
Education:
Adelphi University Garden City, NY Jan 2013 to May 2014 Master of Science in BiologyBeijing City University 2007 to 2012 Bachelor of Science in Biotechnology
The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
Alcohol Derivatives As Kv7 Potassium Channel Openers For Use In Epilepsy Or Seizures
- Valby, DK Mario Rottlãnder - Greve, DK Xiaofang Wang - Shanghai, CN Debasis Das - Shanghai, CN Jian Hong - Shanghai, CN Shu Hui Chen - Calabasas CA, US Jesper Frank Bastlund - Valby, DK Jelena Ivkovic - Valby, DK Karina Krøjer Søby - Valby, DK Morten Grupe Larsen - Valby, DK
Assignee:
H. Lundbeck A/S - Valby
International Classification:
A61K 31/165
Abstract:
The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
Alcohol Derivatives As Kv7 Potassium Channel Openers
- Valby, DK Xiaofang Wang - Shanghai, CN Debasis Das - Shanghai, CN Jian Hong - Shanghai, CN Shu Hui Chen - Calabasas CA, US Anette Graven Sams - Vaerlose, DK Krestian Larsen - Ringsted, DK
International Classification:
C07C 235/08 C07C 255/44
Abstract:
The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
Alcohol Derivatives As Kv7 Potassium Channel Openers
The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.
Alcohol Derivatives As Kv7 Potassium Channel Openers
The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.